Elisabeth Mueller‐Holzner

4.2k total citations · 1 hit paper
31 papers, 2.1k citations indexed

About

Elisabeth Mueller‐Holzner is a scholar working on Molecular Biology, Oncology and Reproductive Medicine. According to data from OpenAlex, Elisabeth Mueller‐Holzner has authored 31 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 13 papers in Oncology and 8 papers in Reproductive Medicine. Recurrent topics in Elisabeth Mueller‐Holzner's work include Epigenetics and DNA Methylation (8 papers), Ovarian cancer diagnosis and treatment (8 papers) and Cancer-related Molecular Pathways (5 papers). Elisabeth Mueller‐Holzner is often cited by papers focused on Epigenetics and DNA Methylation (8 papers), Ovarian cancer diagnosis and treatment (8 papers) and Cancer-related Molecular Pathways (5 papers). Elisabeth Mueller‐Holzner collaborates with scholars based in Austria, United States and Germany. Elisabeth Mueller‐Holzner's co-authors include Christian Marth, Martin Widschwendter, Heidi Fiegl, Gilbert Spizzo, Ian Jacobs, Daniel J. Weisenberger, Joanne Young, Daniel Egle, Mihaela Campan and Peter W. Laird and has published in prestigious journals such as Nature Genetics, Journal of Clinical Oncology and Cancer Research.

In The Last Decade

Elisabeth Mueller‐Holzner

29 papers receiving 2.1k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Epigenetic stem cell signature in cancer

2006 775 citations Martin Widschwendter, Heidi Fiegl et al. Nature Genetics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Elisabeth Mueller‐Holzner Austria	18	1.5k	679	523	199	187	31	2.1k
Sara A. Byron United States	18	1.3k 0.9×	375 0.6×	549 1.0×	161 0.8×	179 1.0×	48	1.9k
Ichiro Onoyama Japan	23	1.8k 1.2×	885 1.3×	329 0.6×	174 0.9×	122 0.7×	58	2.4k
Paul J. van Diest Netherlands	22	833 0.6×	549 0.8×	454 0.9×	177 0.9×	286 1.5×	40	1.6k
Hannes Müller Austria	24	1.8k 1.2×	744 1.1×	727 1.4×	302 1.5×	396 2.1×	44	2.5k
Nikita Makretsov Canada	14	682 0.5×	593 0.9×	380 0.7×	136 0.7×	195 1.0×	19	1.4k
M. A. Tucker United States	14	1.1k 0.7×	1.4k 2.1×	571 1.1×	325 1.6×	185 1.0×	19	2.3k
Ji Shin Lee South Korea	27	1.0k 0.7×	600 0.9×	536 1.0×	141 0.7×	292 1.6×	90	1.9k
Hisaki Nagai Japan	27	1.4k 1.0×	690 1.0×	448 0.9×	289 1.5×	304 1.6×	71	2.2k
Heini Lassus Finland	25	1.0k 0.7×	830 1.2×	555 1.1×	196 1.0×	232 1.2×	44	2.0k
Damian Yap Canada	18	1.3k 0.9×	548 0.8×	671 1.3×	224 1.1×	304 1.6×	24	1.9k

Countries citing papers authored by Elisabeth Mueller‐Holzner

Since Specialization

Citations

This map shows the geographic impact of Elisabeth Mueller‐Holzner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Mueller‐Holzner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Mueller‐Holzner more than expected).

Fields of papers citing papers by Elisabeth Mueller‐Holzner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elisabeth Mueller‐Holzner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Mueller‐Holzner. The network helps show where Elisabeth Mueller‐Holzner may publish in the future.

Co-authorship network of co-authors of Elisabeth Mueller‐Holzner

This figure shows the co-authorship network connecting the top 25 collaborators of Elisabeth Mueller‐Holzner. A scholar is included among the top collaborators of Elisabeth Mueller‐Holzner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elisabeth Mueller‐Holzner. Elisabeth Mueller‐Holzner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Muendlein, Axel, Michael Hubalek, Klaus Gasser, et al.. (2014). Significant survival impact of MACC1 polymorphisms in HER2 positive breast cancer patients. European Journal of Cancer. 50(12). 2134–2141. 27 indexed citations

2.

Muendlein, Axel, Alois Lang, Thomas Winder, et al.. (2012). Association of a common genetic variant of the IGF-1 gene with event-free survival in patients with HER2-positive breast cancer. Journal of Cancer Research and Clinical Oncology. 139(3). 491–498. 14 indexed citations

3.

Zeimet, Alain G., Heidi Fiegl, Hans H. Goebel, et al.. (2011). DNA ploidy, nuclear size, proliferation index and DNA-hypomethylation in ovarian cancer. Gynecologic Oncology. 121(1). 24–31. 49 indexed citations

4.

Fiegl, Heidi, Allison Jones, Cornelia Hauser‐Kronberger, et al.. (2008). Methylated NEUROD1 Promoter is a Marker for Chemosensitivity in Breast Cancer. Clinical Cancer Research. 14(11). 3494–3502. 32 indexed citations

5.

Fiegl, Heidi, Gudrun Windbichler, Elisabeth Mueller‐Holzner, et al.. (2008). HOXA11 DNA methylation—A novel prognostic biomarker in ovarian cancer. International Journal of Cancer. 123(3). 725–729. 79 indexed citations

6.

Hubalek, Michael, Alain G. Zeimet, Consolato Sergi, et al.. (2007). Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma. Archives of Gynecology and Obstetrics. 276(2). 179–183. 35 indexed citations

7.

Mueller‐Holzner, Elisabeth, Thomas Frede, Martin Daniaux, et al.. (2007). Ultrasound-guided core needle biopsy of the breast: does frozen section give an accurate diagnosis?. Breast Cancer Research and Treatment. 106(3). 399–406. 10 indexed citations

8.

Marth, Christian, Gudrun Windbichler, H. Hausmaninger, et al.. (2006). Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study. International Journal of Gynecological Cancer. 16(4). 1522–1528. 48 indexed citations

9.

Spizzo, Gilbert, Philip Went, Stephan Dirnhofer, et al.. (2006). Overexpression of epithelial cell adhesion molecule (Ep-CAM) is an independent prognostic marker for reduced survival of patients with epithelial ovarian cancer. Gynecologic Oncology. 103(2). 483–488. 169 indexed citations

10.

Widschwendter, Martin, Heidi Fiegl, Daniel Egle, et al.. (2006). Epigenetic stem cell signature in cancer. Nature Genetics. 39(2). 157–158. 775 indexed citations breakdown →

11.

Marth, Christian, Gudrun Windbichler, H. Hausmaninger, et al.. (2006). Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study. International Journal of Gynecological Cancer. 16(4). 1522–1528. 8 indexed citations

12.

Fiegl, Heidi, Simone Millinger, Elisabeth Mueller‐Holzner, et al.. (2005). Circulating Tumor-Specific DNA: A Marker for Monitoring Efficacy of Adjuvant Therapy in Cancer Patients. Cancer Research. 65(4). 1141–1145. 208 indexed citations

13.

Concin, Nicole, Gerda Hofstetter, Astrid Berger, et al.. (2005). Clinical Relevance of Dominant-Negative p73 Isoforms for Responsiveness to Chemotherapy and Survival in Ovarian Cancer: Evidence for a Crucial p53-p73 Cross-talk In vivo. Clinical Cancer Research. 11(23). 8372–8383. 72 indexed citations

14.

Widschwendter, Andreas, Thomas Brunhuber, Annemarie Wiedemair, Elisabeth Mueller‐Holzner, & Christian Marth. (2004). Detection of human papillomavirus DNA in breast cancer of patients with cervical cancer history. Journal of Clinical Virology. 31(4). 292–297. 98 indexed citations

15.

Hubalek, Michael, A Ramoni, Elisabeth Mueller‐Holzner, & Christian Marth. (2004). Malignant mixed mesodermal tumor after tamoxifen therapy for breast cancer. Gynecologic Oncology. 95(1). 264–266. 17 indexed citations

16.

Widschwendter, Andreas, Hannes Müller, Michael Hubalek, et al.. (2004). Methylation status and expression of human telomerase reverse transcriptase in ovarian and cervical cancer. Gynecologic Oncology. 93(2). 407–416. 60 indexed citations

17.

Concin, Nicole, Lukas Hefler, Jeroen van Bavel, et al.. (2003). Biological markers in pT1 and pT2 ovarian cancer with lymph node metastases. Gynecologic Oncology. 89(1). 9–15. 8 indexed citations

18.

Ott, Helmut W., Herbert Lindner, Bettina Sarg, et al.. (2003). Calgranulins in cystic fluid and serum from patients with ovarian carcinomas.. PubMed. 63(21). 7507–14. 67 indexed citations

19.

Ott, Hagen, Karl Illmensee, Alain G. Zeimet, et al.. (2002). Die Wertigkeit der Second-Look-Operation bei Patientinnen mit einem Ovarialkarzinom oder Tubenkarzinom mittels einer retrospektiven Vergleichsstudie. Gyn�kologisch-geburtshilfliche Rundschau. 42(4). 217–224. 5 indexed citations

20.

Mueller‐Holzner, Elisabeth, et al.. (2001). Immunohistochemical determination of her2 expression in breast cancer from core biopsy specimens: a reliable predictor of her2 status of the whole tumor. Breast Cancer Research and Treatment. 69(1). 13–19. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact